Mechanism of hyperfiltration

Magee, 2009, Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis, Diabetologia, 52, 691, 10.1007/s00125-009-1268-0 Dahlquist, 2001, Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients, Nephrol Dial Transplant, 16, 1382, 10.1093/ndt/16.7.1382 Jerums, 2010, The clinical significance of hyperfiltration in diabetes, Diabetologia, 53, 2093, 10.1007/s00125-010-1794-9 Tomaszewski, 2007, Glomerular hyperfiltration: a new marker of metabolic risk, Kidney Int, 71, 816, 10.1038/sj.ki.5002160 Anderson, 1993, Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations, Am J Physiol, 265, F477 Craven, 1987, Sequential alterations in glomerular pros-taglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes, Metabolism, 36, 95, 10.1016/0026-0495(87)90070-9 Hostetter, 1981, Glomerular hemodynamics in experimental diabetes mellitus, Kidney Int, 19, 410, 10.1038/ki.1981.33 Zatz, 1985, Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy, Proc Natl Acad Sci USA, 82, 5963, 10.1073/pnas.82.17.5963 Ziyadeh, 2004, Mediators of diabetic renal disease: the case for TGF-beta as the major mediator, J Am Soc Nephrol, 15, S55, 10.1097/01.ASN.0000093460.24823.5B Cherney, 2008, Insights into the regulation of renal hemodynamic function in diabetic mellitus, Curr Diabetes Rev, 4, 280, 10.2174/157339908786241151 Zatz, 1986, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest, 77, 1925, 10.1172/JCI112521 Cherney, 2008, Insights into the regulation of renal hemodynamic function in diabetic mellitus, Curr Diabetes Rev, 4, 280, 10.2174/157339908786241151 Chiarelli, 2000, Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration, Diabetes, 49, 1258, 10.2337/diabetes.49.7.1258 Bank, 1993, Role of EDRF (nitric oxide) in diabetic renal hyperfiltration, Kidney Int, 43, 1306, 10.1038/ki.1993.183 Cherney, 2008, The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes, Diabetes, 57, 688, 10.2337/db07-1230 Cherney, 2008, Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus, Am J Physiol Renal Physiol, 294, F1336, 10.1152/ajprenal.00574.2007 Chihara, 1999, Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure, Hypertension, 34, 843, 10.1161/01.HYP.34.4.843 Brenner, 1996, The hyperfiltration theory: a paradigm shift in nephrology, Kidney Int, 49, 1774, 10.1038/ki.1996.265 Sochett, 2006, Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes, J Am Soc Nephrol, 17, 1703, 10.1681/ASN.2005080872 Ohshiro, 2006, Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice, Diabetes, 55, 3112, 10.2337/db06-0895 De Mattia, 1998, Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy, Am J Hypertens, 11, 983, 10.1016/S0895-7061(98)00094-6 Hopfner, 1999, Endothelin: emerging role in diabetic vascular complications, Diabetologia, 42, 1383, 10.1007/s001250051308 Rabelink, 1994, Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology, Kidney Int, 46, 376, 10.1038/ki.1994.284 Goddard, 2004, Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade, Circulation, 109, 1186, 10.1161/01.CIR.0000118499.69469.51 Mann, 2010, Avosentan for overt diabetic nephropathy, J Am Soc Nephrol, 21, 527, 10.1681/ASN.2009060593 Wenzel, 2009, Avosentan reduces albumin excretion in diabetics with macroalbuminuria, J Am Soc Nephrol, 20, 655, 10.1681/ASN.2008050482 Aires, 2010, BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus, Curr Opin Investig Drugs, 11, 1182 Vervoort, 2005, Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion, Eur J Clin Invest, 35, 330, 10.1111/j.1365-2362.2005.01497.x Vallon, 1995, Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction, J Am Soc Nephrol, 5, 1761, 10.1681/ASN.V5101761 Arakawa, 2001, Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095, Br J Pharmacol, 132, 578, 10.1038/sj.bjp.0703829 Strojek, 2011, Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial, Diabetes Obes Metab, 13, 928, 10.1111/j.1463-1326.2011.01434.x